{"title":"2型糖尿病和基因治疗——CRISPR基因治疗2型糖尿病的前景","authors":"S. Khan","doi":"10.17352/2455-8583.000038","DOIUrl":null,"url":null,"abstract":"Gene therapy has entered a new era with the dawn of CRISPR/Cas9 technology which though \nwere always available in nature but rediscovered to tame into a real-tlife genome editing tool. With the \nmodernization upsurge and changes in ways the “homo sapiens” survived on this planet from hunger to \ncurrent era of exuberance has led to multiple metabolic issues like type-2 diabetes. Notwithstanding the \nrapid emergence of medication to suppress the hyperglycemia and insulin resistance associated with this \nmenace, need has defi nitely emerge to fi nd more personalized and curative dimensions to therapeutics \nof type-2 diabetes mellitus.","PeriodicalId":73168,"journal":{"name":"Global journal of obesity, diabetes and metabolic syndrome","volume":"81 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Type-2 diabetes and gene therapy- The promise of CRISPR gene therapy in type-2 diabetes mellitus\",\"authors\":\"S. Khan\",\"doi\":\"10.17352/2455-8583.000038\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Gene therapy has entered a new era with the dawn of CRISPR/Cas9 technology which though \\nwere always available in nature but rediscovered to tame into a real-tlife genome editing tool. With the \\nmodernization upsurge and changes in ways the “homo sapiens” survived on this planet from hunger to \\ncurrent era of exuberance has led to multiple metabolic issues like type-2 diabetes. Notwithstanding the \\nrapid emergence of medication to suppress the hyperglycemia and insulin resistance associated with this \\nmenace, need has defi nitely emerge to fi nd more personalized and curative dimensions to therapeutics \\nof type-2 diabetes mellitus.\",\"PeriodicalId\":73168,\"journal\":{\"name\":\"Global journal of obesity, diabetes and metabolic syndrome\",\"volume\":\"81 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-07-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Global journal of obesity, diabetes and metabolic syndrome\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17352/2455-8583.000038\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Global journal of obesity, diabetes and metabolic syndrome","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17352/2455-8583.000038","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Type-2 diabetes and gene therapy- The promise of CRISPR gene therapy in type-2 diabetes mellitus
Gene therapy has entered a new era with the dawn of CRISPR/Cas9 technology which though
were always available in nature but rediscovered to tame into a real-tlife genome editing tool. With the
modernization upsurge and changes in ways the “homo sapiens” survived on this planet from hunger to
current era of exuberance has led to multiple metabolic issues like type-2 diabetes. Notwithstanding the
rapid emergence of medication to suppress the hyperglycemia and insulin resistance associated with this
menace, need has defi nitely emerge to fi nd more personalized and curative dimensions to therapeutics
of type-2 diabetes mellitus.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
